Cargando…

Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors

M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of su...

Descripción completa

Detalles Bibliográficos
Autores principales: Zlatopolskiy, Boris D., Neumaier, Felix, Rüngeler, Till, Drewes, Birte, Kolks, Niklas, Neumaier, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355535/
https://www.ncbi.nlm.nih.gov/pubmed/32585815
http://dx.doi.org/10.3390/molecules25122880
_version_ 1783558298284326912
author Zlatopolskiy, Boris D.
Neumaier, Felix
Rüngeler, Till
Drewes, Birte
Kolks, Niklas
Neumaier, Bernd
author_facet Zlatopolskiy, Boris D.
Neumaier, Felix
Rüngeler, Till
Drewes, Birte
Kolks, Niklas
Neumaier, Bernd
author_sort Zlatopolskiy, Boris D.
collection PubMed
description M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of subtype-selective positron emission tomography (PET) tracers for mAChRs resulting in the development of several (11)C-labeled probes. However, protocols for the preparation of (18)F-labeled mAChR-ligands have not been published so far. Here, we describe a straightforward procedure for the preparation of an (18)F-labeled M(1) mAChR agonist and its corresponding pinacol boronate radiolabeling precursor and the non-radioactive reference compound. The target compounds were prepared from commercially available aryl fluorides and Boc protected 4-aminopiperidine using a convergent reaction protocol. The radiolabeling precursor was prepared by a modification of the Miyaura reaction and labeled via the alcohol-enhanced Cu-mediated radiofluorination. The developed procedure afforded the radiotracer in a non-decay-corrected radiochemical yield of 17 ± 3% (n = 3) and in excellent radiochemical purity (>99%) on a preparative scale. Taken together, we developed a straightforward protocol for the preparation of an (18)F-labeled M(1) mAChR agonist that is amenable for automation and thus provides an important step towards the routine production of a (18)F-labeled M(1) selective PET tracer for experimental and diagnostic applications.
format Online
Article
Text
id pubmed-7355535
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73555352020-07-23 Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors Zlatopolskiy, Boris D. Neumaier, Felix Rüngeler, Till Drewes, Birte Kolks, Niklas Neumaier, Bernd Molecules Article M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of subtype-selective positron emission tomography (PET) tracers for mAChRs resulting in the development of several (11)C-labeled probes. However, protocols for the preparation of (18)F-labeled mAChR-ligands have not been published so far. Here, we describe a straightforward procedure for the preparation of an (18)F-labeled M(1) mAChR agonist and its corresponding pinacol boronate radiolabeling precursor and the non-radioactive reference compound. The target compounds were prepared from commercially available aryl fluorides and Boc protected 4-aminopiperidine using a convergent reaction protocol. The radiolabeling precursor was prepared by a modification of the Miyaura reaction and labeled via the alcohol-enhanced Cu-mediated radiofluorination. The developed procedure afforded the radiotracer in a non-decay-corrected radiochemical yield of 17 ± 3% (n = 3) and in excellent radiochemical purity (>99%) on a preparative scale. Taken together, we developed a straightforward protocol for the preparation of an (18)F-labeled M(1) mAChR agonist that is amenable for automation and thus provides an important step towards the routine production of a (18)F-labeled M(1) selective PET tracer for experimental and diagnostic applications. MDPI 2020-06-23 /pmc/articles/PMC7355535/ /pubmed/32585815 http://dx.doi.org/10.3390/molecules25122880 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zlatopolskiy, Boris D.
Neumaier, Felix
Rüngeler, Till
Drewes, Birte
Kolks, Niklas
Neumaier, Bernd
Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
title Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
title_full Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
title_fullStr Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
title_full_unstemmed Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
title_short Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
title_sort preparation of a first (18)f-labeled agonist for m(1) muscarinic acetylcholine receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355535/
https://www.ncbi.nlm.nih.gov/pubmed/32585815
http://dx.doi.org/10.3390/molecules25122880
work_keys_str_mv AT zlatopolskiyborisd preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors
AT neumaierfelix preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors
AT rungelertill preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors
AT drewesbirte preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors
AT kolksniklas preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors
AT neumaierbernd preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors